Summary
The pharmacokinetics of dothiepin were evaluated in 9 depressed patients following a single oral dose of 75mg. Blood and plasma concentrations of dothiepin and 2 major metabolites, northiaden and dothiepin S-oxide, were measured by gas chromatography/mass fragmentography. The mean (±SD) peak plasma concentrations of dothiepin were 49 ±27 μg/L at 3 ± l.2h. Mean (± SD) estimates of other parameters were as follows: absorption half-life 1.1 ± 1.1h; distribution half-life 2.2 ± 0.8h; elimination half-life 25 ± 7h; apparent volume of distribution 70 ± 62 L/kg; and oral clearance 2.1 ± 1.6 L/kg/h.
The mean (±SD) peak plasma concentration of dothiepin S-oxide was 125 ± 43 μg/L at 3.5 ± 1.3h with an elimination half-life of 22 ± 12h. The mean peak plasma concentration of northiaden was 6 ± 3 μg/L at 4.5 ± 1.1h, with an elimination half-life of 31 ±12h. No significant differences were found in pharmacokinetic parameters compared with a previous study in 7 healthy volunteers.
When data for the patients and healthy volunteers were combined (n = 16), pharmacokinetic parameters were not found to be affected by age. However, a significant difference was found between males and females for the elimination half-lives of dothiepin and northiaden, and for the apparent volume of distribution of dothiepin.
The 24-hour blood/plasma concentrations of dothiepin and dothiepin S-oxide accurately predicted the steady-state concentrations obtained following 4 weeks’ treatment with dothiepin 150mg nocte.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexanderson, B.: Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steadystate plasma concentrations from single-dose plasma-level data. European Journal of Clinical Pharmacology 4: 82–91 (1972a).
Alexanderson, B.: Pharmacokinetics of desmethylimipramine and nortriptyline in man after single and multiple oral doses — A cross-over study. European Journal of Clinical Pharmacology 5: 1–10 (1972b).
Alexanderson, B.: Prediction of steady-state plasma levels of nortriptyline from single oral dose kinetics: a study in twins. European Journal of Clinical Pharmacology 6: 44–53 (1973).
Alvan, G.; Borgå, O.; Lind, M.; Palmer, L. and Siwers, B.: First pass hydroxylation of nortriptyline: concentrations of parent drug and major metabolites in plasma. European Journal of Clinical Pharmacology 11: 219–224 (1977).
Braithwaite, R.; Montgomery, S.; and Dawling, S.: Nortriptyline in depressed patients with high plasma levels. II. Clinical Pharmacology and Therapeutics 23: 303–308 (1978).
Brunswick, D.J.; Amsterdam, J.D.; Mendels, J.; and Stern, S.L.: Prediction of steady-state imipramine and desmethylimipramine plasma concentrations from single-dose date. Clinical Pharmacology and Therapeutics 25: 605–610 (1979).
Cooper, T.B. and Simpson, G.M.: Prediction of individual dosage of nortriptyline. American Journal of Psychiatry 135: 333–335 (1978).
Curry, S.H.: Drug disposition and pharmacokinetics with a consideration of pharmacological and clinical relationships. (Blackwell Scientific Publications, London 1977).
Dawling, S.; Crome, P. and Braithwaite, R.: Pharmacokinetics of single oral doses of nortriptyline in depressed elderly hospital patients and young healthy volunteers. Clinical Pharmacokinetics 5: 394–401 (1980).
Maguire, K.P.; Burrows, G.D.; Norman, T.R. and Scoggins, B.A.: Metabolism and Pharmacokinetics of dothiepin. British Journal of Clinical Pharmacology 12: 405–409 (1981a).
Maguire, K.P.; Norman, T.R.; Burrows, G.D., and Scoggins, B.A.: Simultaneous measurement of dothiepin and its major metabolites in plasma and whole blood by gas-chromatographymass fragmentography. Journal of Chromatography 222: 399–408 (1981b).
Maguire, K.P.; Norman, T.R.; McIntyre, I.; Burrows, G.D. and Davies, B.: Blood and plasma concentrations of dothiepin and its major metabolites and clinical response. Journal of Affective Disorders 4: 41–48 (1982).
Montgomery, S.A.; McAuley, R.; Montgomery, D.B.; Braithwaite, R.A. and Dawling, S.: Dosage adjustment from simple nortriptyline spot level predictor tests in depressed patients. Clinical Pharmacokinetics 4: 129–136 (1979).
Potter, W.Z.; Zavadil, A.P.; Kopin, I.J. and Goodwin, F.K.: Single-dose kinetics predict steady-state concentrations of imipramine and desipramine. Archives of General Psychiatry 37: 314–320 (1980).
Redmond, F.C.; Bowden, C.L. and Lehman, L.D.: Single-dose prediction of amitriptyline and nortriptyline requirement in unipolar depression. Current Therapeutic Research 27: 635–642 (1980).
Rees, J.A.: Clinical interpretation of pharmacokinetic data on dothiepin hydrochloride (Dosulepin, Prothiaden). Journal of International Medical Research 9: 98–102 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maguire, K.P., Norman, T.R., McIntyre, I. et al. Clinical Pharmacokinetics of Dothiepin. Clin Pharmacokinet 8, 179–185 (1983). https://doi.org/10.2165/00003088-198308020-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198308020-00004